AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 49 filers reported holding AQUINOX PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 2.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $39,000 | -11.4% | 16,478 | 0.0% | 0.00% | – |
| Q1 2019 | $44,000 | +18.9% | 16,478 | -2.9% | 0.00% | – |
| Q4 2018 | $37,000 | -26.0% | 16,968 | 0.0% | 0.00% | – |
| Q3 2018 | $50,000 | +11.1% | 16,968 | 0.0% | 0.00% | – |
| Q2 2018 | $45,000 | -85.0% | 16,968 | -20.6% | 0.00% | – |
| Q1 2018 | $301,000 | +50.5% | 21,370 | +25.9% | 0.00% | – |
| Q4 2017 | $200,000 | -39.4% | 16,968 | -27.1% | 0.00% | – |
| Q3 2017 | $330,000 | +0.9% | 23,260 | 0.0% | 0.00% | – |
| Q2 2017 | $327,000 | -1.8% | 23,260 | +16.5% | 0.00% | – |
| Q1 2017 | $333,000 | +0.6% | 19,961 | -0.5% | 0.00% | – |
| Q4 2016 | $331,000 | +47.8% | 20,053 | +19.6% | 0.00% | – |
| Q3 2016 | $224,000 | +94.8% | 16,761 | -3.5% | 0.00% | – |
| Q2 2016 | $115,000 | -52.1% | 17,377 | -36.2% | 0.00% | – |
| Q1 2016 | $240,000 | +10.6% | 27,237 | +56.7% | 0.00% | – |
| Q4 2015 | $217,000 | -11.1% | 17,377 | 0.0% | 0.00% | – |
| Q3 2015 | $244,000 | – | 17,377 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 1,396,071 | $19,643,000 | 2.25% |
| Boxer Capital, LLC | 525,000 | $7,387,000 | 1.76% |
| Baker Brothers Advisors | 10,934,154 | $153,844,000 | 1.34% |
| EMORY UNIVERSITY | 105,815 | $1,489,000 | 1.32% |
| Ghost Tree Capital, LLC | 300,000 | $4,221,000 | 0.88% |
| UNIVERSITY OF NOTRE DAME DU LAC | 171,217 | $2,409,000 | 0.71% |
| NEXTHERA CAPITAL LP | 90,700 | $1,276,000 | 0.56% |
| Eventide Asset Management | 175,000 | $2,462,000 | 0.15% |
| SPHERA FUNDS MANAGEMENT LTD. | 62,085 | $874,000 | 0.15% |
| ASCEND CAPITAL, LLC | 214,328 | $3,017,000 | 0.14% |